Literature DB >> 1721417

Phase II study of FK 506 for allogeneic bone marrow transplantation.

T Masaoka1, H Shibata, E Kakishita, A Kanamaru, Y Takemoto, Y Moriyama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721417

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Systemic FK506 improved tear secretion in dry eye associated with chronic graft versus host disease.

Authors:  S Aoki; H Mizote; A Minamoto; M Suzuki; H K Mishima; H Tanaka
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

2.  Tacrolimus in pediatric renal transplantation.

Authors:  R Shapiro; V P Scantlebury; M L Jordan; C Vivas; H A Gritsch; D Ellis; N Gilboa; S Lombardozzi-Lane; W Irish; J J Fung; T R Hakala; R L Simmons; T E Starzl
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

3.  Renal transplantation at the University of Pittsburgh: the impact of FK506.

Authors:  R Shapiro; M Jordan; V P Scantlebury; C Vivas; H A Gritsch; A S Rao; M Trucco; A Zeevi; A J Demetris; P Randhawa
Journal:  Clin Transpl       Date:  1994

Review 4.  The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience.

Authors:  R Shapiro; M L Jordan; V P Scantlebury; C Vivas; H A Gritsch; R J Corry; F Egidi; J McCauley; D Ellis; N Gilboa
Journal:  Clin Transpl       Date:  1995

5.  Ocular manifestations of graft-versus-host disease.

Authors:  Amr Nassar; Khalid F Tabbara; Mahmoud Aljurf
Journal:  Saudi J Ophthalmol       Date:  2013-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.